These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15196436)

  • 1. [Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].
    Han Y; Li CL; Lu L; Zhou CX; Ma WB; Wang DM; Zhang SR
    Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):158-60. PubMed ID: 15196436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
    Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
    Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
    Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
    Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
    Blood Purif; 2008; 26(4):317-21. PubMed ID: 18463433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Antoniadi G; Kazila P; Pliakos K; Liakopoulos V; Markala D
    Nephrology (Carlton); 2009 Aug; 14(5):471-5. PubMed ID: 19486472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma.
    Cardi G; Heaney JA; Schned AR; Phillips DM; Branda MT; Ernstoff MS
    Cancer Res; 1997 Aug; 57(16):3517-9. PubMed ID: 9270022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
    Kono K; Ressing ME; Brandt RM; Melief CJ; Potkul RK; Andersson B; Petersson M; Kast WM; Kiessling R
    Clin Cancer Res; 1996 Nov; 2(11):1825-8. PubMed ID: 9816136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.
    Nakagomi H; Petersson M; Magnusson I; Juhlin C; Matsuda M; Mellstedt H; Taupin JL; Vivier E; Anderson P; Kiessling R
    Cancer Res; 1993 Dec; 53(23):5610-2. PubMed ID: 8242612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.
    Ciszak L; Kosmaczewska A; Werynska B; Szteblich A; Jankowska R; Frydecka I
    Oncol Rep; 2009 Jan; 21(1):173-84. PubMed ID: 19082459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients.
    Frydecka I; Zimecki M; Bocko D; Kosmaczewska A; Teodorowska R; Ciszak L; Kruzel M; Wlodarska-Polinsk J; Kuliczkowski K; Kornafel J
    Anticancer Res; 2002; 22(3):1897-901. PubMed ID: 12168890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells activated in vitro as immunotherapy for renal cell carcinoma: characterization of 2 effector T-cell populations.
    Garlie NK; Siebenlist RE; Lefever AV
    J Urol; 2001 Jul; 166(1):299-303. PubMed ID: 11435890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte therapy of renal cell carcinoma.
    Dillman RO
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1041-51. PubMed ID: 16336095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
    Kuss I; Saito T; Johnson JT; Whiteside TL
    Clin Cancer Res; 1999 Feb; 5(2):329-34. PubMed ID: 10037182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma.
    Hermann GG
    APMIS Suppl; 1993; 35():1-26. PubMed ID: 8251200
    [No Abstract]   [Full Text] [Related]  

  • 17. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.
    Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H
    Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
    Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
    Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
    Finke JH; Zea AH; Stanley J; Longo DL; Mizoguchi H; Tubbs RR; Wiltrout RH; O'Shea JJ; Kudoh S; Klein E
    Cancer Res; 1993 Dec; 53(23):5613-6. PubMed ID: 8242613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
    Am J Nephrol; 2008; 28(1):152-7. PubMed ID: 17951997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.